Ninth International Congress on Targeted Therapies in Cancer

Venue: TBA

Location: Washington, Washington DC, United States

Event Date/Time: Aug 20, 2010 End Date/Time: Aug 22, 2010
Registration Date: Aug 19, 2010
Early Registration Date: Apr 30, 2010
Report as Spam

Description

a unique opportunity for medical oncologists, translational researchers (MDs and PhDs), and drug developers from academia and industry to learn from and interact with international leaders in the field of novel therapeutic and drug discovery platforms and to obtain a preview of new agents in development for the next generation of cancer therapy.

Topics to be included:

Concise overviews of the biology underpinning the development of new targeted agents
Expert analysis of therapeutic agents targeting intracellular signaling, cell surface receptors, and the tumor microenvironment
Discussion of novel therapeutic discovery platforms
Clinically oriented lectures to provide physicians with practical applications for improved patient care
Target Audience

This educational program is directed toward medical oncologists, translational researchers (MDs and PhDs), and drug developers from academia and industry interested in cancer drug development. Other health care professionals interested in the treatment of cancer are also invited to attend.

Venue

Additional Information

Continuing Education Information Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This activity is approved for AMA PRA Category 1 Creditâ„¢ Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME